Gonadotrophin-releasing hormone analogues for endometriosis

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 7, 2021, Pages

  Veth, Veerle B ^a   van de Kar, Majorie ^a   Duffy, James MN ^b   van Wely, Madelon ^c   Mijatovic, Velja ^d   Maas, Jacques WM ^e  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b The Fetal Medicine Research Institute   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d AMSTERDAM UMC   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DANAZOL; GESTAGEN; GESTRINONE; GONADORELIN DERIVATIVE; PLACEBO;

ADVERSE DRUG REACTION; ARTICLE; BONE DENSITY; CLINICAL OUTCOME; COCHRANE LIBRARY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIOSIS; HUMAN; INTERVENTION STUDY; META ANALYSIS; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT; STUDY DESIGN; SYSTEMATIC REVIEW;

EID: 17844391236     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD014788     Document Type: Article

References (37)

1. Audebert A, Descamps P, Marret H, Ory-Lavollee L, Bailleul F, Hamamah S. Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study. European Journal of Obstetrics, Gynecology and Reproductive Biology 1998;79(2):145-48. [DOI: 10.1016/s0301-2115(98)00028-1]
2. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JMN. Laparoscopic surgery for endometriosis. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No: CD011031. [DOI: 10.1002/14651858.CD011031]
3. Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No: CD002122. [DOI: 10.1002/14651858.CD002122.pub2]
4. Brown J, Crawford TJ, Datta S, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No: CD001019. [DOI: 10.1002/14651858.CD001019]
5. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertility and Sterility 2012;3:511-9. [DOI: 10.1016/j.fertnstert.2012.06.029]
6. Chen I, Veth VB, Choudhry AJ, Murji A, Zakhari A, Black AY, et al. Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No: CD003678. [DOI: 10.1002/14651858.CD003678.pub3]
7. Darwish A, Hassanin MS, Abou Sekkin IA. Epidemiology and risk factors associated with laparoscopicaly diagnosed typical and atypical endometriosis among Egyptian women. Middle East Fertility Society Journal 2006;11:196-201.
8. Duffy JMN, Hirsch M, Vercoe M, Abbott J, Barker C, Collura B, et al. A core outcome set for future endometriosis research: an international consensus development study [A core outcome set for future endometriosis research: an international consensus development study]. British Journal of Obstetrics and Gynaecology 2020;127(8):967-74. [DOI: 10.1111/1471-0528.16157] [PMID: 32227676]
9. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Human Reproduction 2014;3:400-12. [DOI: 10.1093/humrep/det457]
10. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstetrics and gynecology clinics of North America 1997;24:235-58. [DOI: 10.1016/s0889-8545(05)70302-8 Abstract] [PMID: 9163765]
11. Flower A, Liu JP, Lewith G, Little P, Li Q. Chinese herbal medicine for endometriosis. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No: CD006568. [DOI: 10.1002/14651858.CD006568.pub3]
12. Fu J, Song H, Zhou M, Zhu H, Wang Y, Chen H, Huang W. Progesterone receptor modulators for endometriosis. Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No: CD009881. [DOI: 10.1002/14651858.CD009881.pub2]
13. Giudice LC. Clinical practice: endometriosis. New England Journal of Medicine 2010;25:2389-98. [DOI: 10.1056/NEJMcp1000274]
14. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook.
15. Houda MR, Grant NH. Gonadotrophin antagonists for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD011446. [DOI: 10.1002/14651858.CD011446]
16. Klein S, D'Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? a prospective Belgian study. Reproductive Biomedical Online 2013;28(1):116-224. [DOI: 10.1016/j.rbmo.2013.09.020]
17. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook.
18. Levander G, Normann P. The pathogenesis of endometriosis; an experimental study. Acta Obstetricia et Gynecologica Scandinavica 1955;34(4):366-98. [DOI: 10.3109/00016345509158287]
19. Macer ML and Taylor HS. Endometriosis and Infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility. Obstetrics and Gynecology Clinics of North America 2013;39(4):535-549. [DOI: 10.1016/j.ogc.2012.10.002]
20. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Human Reproduction 1991;6:544-9. [PMID: 1918305]
21. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstetrics and Gynecology 1996;87(3):321-7. [DOI: 10.1016/0029-7844(95)00458-0]
22. Meuleman C, Vandenabeele B, Fieuws S, Spiessend C, Timmermans D, D'Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertility and Sterility 2009;92(1):68-74. [DOI: 10.1016/j.fertnstert.2008.04.056]
23. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, Guyatt GH. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook 2021.
24. Shaw RW. GnRH analogues in the treatment of endometriosis -rationale and efficacy. London: Kluwer Academic Publishers, 1991.
25. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Human Reproduction 2021;27(5):1292-9. [DOI: 10.1093/humrep/des073]
26. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Human Reproduction Update 2011;17(3):327–46. [PMID: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072022/]
27. van der Linden PJ. Theories on the pathogenesis of endometriosis. Human Reproduction 1996;3:53-65. [DOI: 10.1093/humrep/11.suppl_3.53.]
28. van Hoesel MH, Chen YL, Zheng A, Wan Q, Mourad SM. Selective oestrogen receptor modulators (SERMs) for endometriosis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No: CD011169. [DOI: 10.1002/14651858.CD011169.pub2]
29. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nature Reviews, Endocrinology 2014;5:261-75. [DOI: 10.1038/nrendo.2013.255]
30. Viganò P, Parazzini F, Somigliana E, Vercellini P,. Endometriosis: epidemiology and aetiological factors. Best Practice & Research Clinical Obstetrics & Gynaecology 2004;18(2):177-200. [DOI: 10.1016/j.bpobgyn.2004.01.007]
31. Vigano P, Candiani M, Monno A, Giacomini E, Vercellini P, Somigliana E. Time to redefine endometriosis including its pro-fibrotic nature. Human Reproduction 2018;1(33(3)):347-52. [PMID: https://pubmed.ncbi.nlm.nih.gov/29206943/]
32. Wheeler JM. Epidemiology of endometriosis-associated infertility. Journal of Reproductive Medicine 1989;34:41-6. [PMID: 2704007]
33. Whitehouse RW, Adams JE, Bancroft K, Vaughan-Williams CA, Elstein M. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis. Clinical Endocrinology 1990;3(33):365-73. [PMID: MEDLINE: 91070821]
34. Ylikorkala O, Nilsson G, Hirvonen E, Viinikka L. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. Gynaecological Endocrinology 1990;4(4):251-60. [PMID: MEDLINE: 91188927]
35. Zhu X, Hamilton KD, McNicol ED. Acupuncture for pain in endometriosis. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No: CD007864. [DOI: 10.1002/14651858.CD007864.pub2]
36. Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No: CD008475. [DOI: 10.1002/14651858.CD008475.pub2]
37. Farmer JE, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD001297. [DOI: 10.1002/14651858.CD001297]